Core Viewpoint - The stock price of Ruimait has experienced fluctuations, with a recent decline of 2.00% and a total market capitalization of 8.107 billion yuan. The company has seen a net outflow of funds, indicating potential investor caution [1]. Group 1: Stock Performance - Ruimait's stock has increased by 5.57% year-to-date, with a recent decline of 1.16% over the last five trading days. Over the past 20 days, the stock has risen by 6.09%, while it has increased by 3.79% over the last 60 days [2]. - As of January 16, the stock was trading at 90.48 yuan per share, with a trading volume of 50.0166 million yuan and a turnover rate of 0.78% [1]. Group 2: Company Overview - Ruimait Medical Technology Co., Ltd. was established on July 27, 2001, and went public on November 1, 2022. The company specializes in the research, production, and sales of medical devices and consumables in the respiratory health sector [2]. - The company's main business revenue composition includes home respiratory therapy products (64.19%), consumables (32.67%), medical products (3.05%), and others (0.10%) [2]. Group 3: Financial Performance - For the period from January to September 2025, Ruimait achieved an operating income of 808 million yuan, representing a year-on-year growth of 34.24%. The net profit attributable to shareholders was 180 million yuan, reflecting a year-on-year increase of 43.87% [3]. - Since its A-share listing, Ruimait has distributed a total of 228 million yuan in dividends [4]. Group 4: Shareholder Information - As of September 30, 2025, Ruimait had 7,971 shareholders, an increase of 16.36% from the previous period. The average number of circulating shares per person decreased by 14.20% to 7,080 shares [3]. - Among the top ten circulating shareholders, Huatai-PineBridge Healthcare Mixed Fund is the sixth largest, holding 1.2953 million shares as a new shareholder [4].
瑞迈特跌2.00%，成交额5001.66万元，主力资金净流出553.58万元